GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » DNA Chip Research Inc (TSE:2397) » Definitions » ROIC %

DNA Chip Research (TSE:2397) ROIC % : -68.45% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is DNA Chip Research ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. DNA Chip Research's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was -68.45%.

As of today (2024-06-05), DNA Chip Research's WACC % is 13.41%. DNA Chip Research's ROIC % is -60.12% (calculated using TTM income statement data). DNA Chip Research earns returns that do not match up to its cost of capital. It will destroy value as it grows.


DNA Chip Research ROIC % Historical Data

The historical data trend for DNA Chip Research's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Chip Research ROIC % Chart

DNA Chip Research Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -78.52 -46.39 -47.52 -49.93 -84.86

DNA Chip Research Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -105.86 -33.17 -80.00 -58.94 -68.45

Competitive Comparison of DNA Chip Research's ROIC %

For the Diagnostics & Research subindustry, DNA Chip Research's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DNA Chip Research's ROIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, DNA Chip Research's ROIC % distribution charts can be found below:

* The bar in red indicates where DNA Chip Research's ROIC % falls into.



DNA Chip Research ROIC % Calculation

DNA Chip Research's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Mar. 2023 is calculated as:

ROIC % (A: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2022 ) + Invested Capital (A: Mar. 2023 ))/ count )
=-362.89 * ( 1 - -0.37% )/( (330.663 + 527.818)/ 2 )
=-364.232693/429.2405
=-84.86 %

where

Invested Capital(A: Mar. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=890.034 - 70.217 - ( 489.154 - max(0, 99.329 - 710.208+489.154))
=330.663

Invested Capital(A: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=871.134 - 67.955 - ( 275.361 - max(0, 121.495 - 525.122+275.361))
=527.818

DNA Chip Research's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-301.444 * ( 1 - -0.63% )/( (453.084 + 433.253)/ 2 )
=-303.3430972/443.1685
=-68.45 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=706.674 - 46.181 - ( 207.409 - max(0, 117.818 - 380.248+207.409))
=453.084

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=651.921 - 72.783 - ( 145.885 - max(0, 138.597 - 335.759+145.885))
=433.253

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DNA Chip Research  (TSE:2397) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, DNA Chip Research's WACC % is 13.41%. DNA Chip Research's ROIC % is -60.12% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


DNA Chip Research ROIC % Related Terms

Thank you for viewing the detailed overview of DNA Chip Research's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


DNA Chip Research (TSE:2397) Business Description

Traded in Other Exchanges
N/A
Address
1-1-43 Suehirocho, Tsurumi-ku, Yokohama, JPN
DNA Chip Research Inc is specializing in the development of DNA microarrays. Its major business is focused on research and development, contract research service, and diagnostic support service. The company provides a wide variety of analytical services, from DNA chips to state-of-the-art next-generation sequencing. In addition, it provides consultation on experimental planning, sample preparation, statistical analysis, and manuscript preparation, catering to researchers' needs and requirements.

DNA Chip Research (TSE:2397) Headlines

No Headlines